Second Cancers in a Patient with Gastric MALT Lymphoma

Mucosa-associated lymphoid tissue (MALT) lymphoma is an extranodal low-grade B-cell lymphoma, which is thought to arise from a background of chronic immune stimulation, bacterial, viral, or autoimmune stimuli. Treatment advances have increased the number of MALT lymphoma survivors, but there is stil...

Descripción completa

Detalles Bibliográficos
Autores principales: Navsaria, Lucy, Badillo, Alfonso, Wang, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244950/
https://www.ncbi.nlm.nih.gov/pubmed/32508929
http://dx.doi.org/10.1155/2020/1213596
_version_ 1783537664257949696
author Navsaria, Lucy
Badillo, Alfonso
Wang, Michael
author_facet Navsaria, Lucy
Badillo, Alfonso
Wang, Michael
author_sort Navsaria, Lucy
collection PubMed
description Mucosa-associated lymphoid tissue (MALT) lymphoma is an extranodal low-grade B-cell lymphoma, which is thought to arise from a background of chronic immune stimulation, bacterial, viral, or autoimmune stimuli. Treatment advances have increased the number of MALT lymphoma survivors, but there is still debate as to whether these patients are at a higher risk of developing second cancers. This is a case of a long-surviving (>20 years) patient with multiple diagnosed malignancies following MALT lymphoma. We describe how modern oncological treatment plans can provide patients with prolonged survival and increased quality of life despite increasing age and multiple malignancies.
format Online
Article
Text
id pubmed-7244950
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72449502020-06-05 Second Cancers in a Patient with Gastric MALT Lymphoma Navsaria, Lucy Badillo, Alfonso Wang, Michael Case Rep Med Case Report Mucosa-associated lymphoid tissue (MALT) lymphoma is an extranodal low-grade B-cell lymphoma, which is thought to arise from a background of chronic immune stimulation, bacterial, viral, or autoimmune stimuli. Treatment advances have increased the number of MALT lymphoma survivors, but there is still debate as to whether these patients are at a higher risk of developing second cancers. This is a case of a long-surviving (>20 years) patient with multiple diagnosed malignancies following MALT lymphoma. We describe how modern oncological treatment plans can provide patients with prolonged survival and increased quality of life despite increasing age and multiple malignancies. Hindawi 2020-05-13 /pmc/articles/PMC7244950/ /pubmed/32508929 http://dx.doi.org/10.1155/2020/1213596 Text en Copyright © 2020 Lucy Navsaria et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Navsaria, Lucy
Badillo, Alfonso
Wang, Michael
Second Cancers in a Patient with Gastric MALT Lymphoma
title Second Cancers in a Patient with Gastric MALT Lymphoma
title_full Second Cancers in a Patient with Gastric MALT Lymphoma
title_fullStr Second Cancers in a Patient with Gastric MALT Lymphoma
title_full_unstemmed Second Cancers in a Patient with Gastric MALT Lymphoma
title_short Second Cancers in a Patient with Gastric MALT Lymphoma
title_sort second cancers in a patient with gastric malt lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244950/
https://www.ncbi.nlm.nih.gov/pubmed/32508929
http://dx.doi.org/10.1155/2020/1213596
work_keys_str_mv AT navsarialucy secondcancersinapatientwithgastricmaltlymphoma
AT badilloalfonso secondcancersinapatientwithgastricmaltlymphoma
AT wangmichael secondcancersinapatientwithgastricmaltlymphoma

Ejemplares similares